Clinical Development Network Across Global Newsroom Participants Member Login Submit an RFP

Solutions · Global Health Programs | Clinical Research and Health Systems | Guosa Life Sciences

Advancing Global Health Through Partnership

Clinical Development Solutions for Public Health Impact

Global health programs require more than scientific expertise. They require collaboration, operational agility, sustainable capacity development and an understanding of diverse healthcare systems.

Submit an RFP

Home/Solutions/Global Health Programs | Clinical Research and Health Systems | Guosa Life Sciences

Overview

Clinical Development Solutions for Public Health Impact

Governments, multilateral organizations, NGOs, philanthropic foundations and development partners increasingly seek integrated solutions capable of delivering measurable public health outcomes.

Guosa Life Sciences partners with public and private organizations to design, implement and strengthen clinical research and health programs that improve access to innovation, expand research capacity and support resilient healthcare systems.

Global health program research and delivery

Capabilities

What We Deliver

Programs

Public health research
Implementation science
Vaccine and outbreak preparedness
Health systems strengthening

Capacity and Partnership

Capacity development
Monitoring and evaluation
Community engagement
International partnerships

The GLS Advantage

Strengthened by the Whole Enterprise

Every solution delivered by Guosa Life Sciences is strengthened by the broader enterprise. Our operational teams are supported by evidence-based Insights, professional development through GLS Academy, collaborative partnerships within the Clinical Development Network and a quality-driven delivery model, enabling scientifically sound, operationally efficient and scalable solutions.

Explore the Enterprise

Evidence-based Insights
GLS Academy development
Clinical Development Network
Integrated quality systems
Technology-enabled delivery
Global operational reach

The capability

What We Actually Do

We support governments, ministries, NGOs, donors and multilateral organizations: public health research, implementation science, surveillance and outbreak response studies, health systems research, and the capacity development that makes programs sustainable after the funding period ends.

Programs in this space are judged on delivery and on legacy. We design so that the institutions involved retain capability afterward: local investigators lead, staff are trained rather than substituted, and data and analysis capacity stays in-country rather than leaving with the implementing partner.

Regulatory considerations

Donor compliance and WHO prequalification

Donor and multilateral funding carries compliance obligations distinct from regulatory ones. Reporting formats, procurement rules, audit rights, data sharing expectations and publication requirements are set by the funder and are frequently more prescriptive than the regulatory requirements applying to the same study. Programs that treat these as administrative overhead rather than as design constraints tend to discover the conflict late.

Where a program is intended to support public-sector procurement, WHO prequalification is the gateway to tendering with Gavi, UNICEF, the Global Fund and PEPFAR. Its evidence requirements should inform trial design from the protocol stage rather than being addressed after readout, and the same applies to the emerging continental pathways: the African Medicines Agency, operational in Kigali, is developing reliance mechanisms intended to reduce duplicate assessment across African markets.

How an engagement runs

The Sequence

1. Design

Study or program design aligned to both the scientific question and the funder’s compliance framework, with capacity objectives defined explicitly.

2. Set-up

Institutional agreements, ethics and regulatory approvals, and the training and systems local partners will need to lead delivery.

3. Delivery

Implementation with local leadership, monitored against agreed indicators and reported in the funder’s required format.

4. Transition

Handover of systems, data and capability, with a documented assessment of what the institution retains.

What you receive

Deliverables

A design aligned to funder compliance requirements. Institutional agreements and approvals in place. Delivery reporting in the required format. A documented capability handover at transition.

Evidence and context

The Research Behind This Work

Our operating assumptions are published rather than asserted. The Future of Clinical Trials in Africa sets out why study performance is increasingly determined by ecosystem maturity rather than site selection, and The Untapped Advantage makes the case that institutions, not regions, are the right unit of qualification. Both are available in full, with executive briefs for readers who want the argument in a shorter form.

The Future of Clinical Trials in Africa The Untapped Advantage

Public Health

Public-health research.

Explore

Vaccines and Infectious Diseases

Preparedness programs.

Explore

The Network

Community and institutions.

Explore

AE-PCRN

African research capacity.

Visit AE-PCRN at ae-pcrn.org

FAQ

Common Questions

Who do you partner with on global health?

Governments, multilateral and non-governmental organizations, philanthropic foundations and development partners seeking measurable public-health outcomes.

Do you support capacity development?

Yes. Sustainable capacity development and health-systems strengthening are central, reinforced by GLS Academy and the Clinical Development Network.

Let's Discuss Your Program

Tell us about your objectives and our multidisciplinary team will scope an integrated, flexible solution.

Submit an RFP

Advancing Global Health Through Partnership

Clinical Development Solutions for Public Health Impact

What We Deliver

Programs

Capacity and Partnership

Strengthened by the Whole Enterprise

What We Actually Do

Donor compliance and WHO prequalification

The Sequence

1. Design

2. Set-up

3. Delivery

4. Transition

Deliverables

The Research Behind This Work

Explore Related Capabilities

Public Health

Vaccines and Infectious Diseases

The Network

AE-PCRN

Common Questions

Let's Discuss Your Program